PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, USA.\', \'Texas Biomedical Research Institute, San Antonio, TX, USA.\', \'Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA.\', \'Aridis Pharmaceuticals, San Jose, CA, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1016/j.xcrm.2021.100218
?:doi
?:hasPublicationType
?:journal
  • Cell reports. Medicine
is ?:pmid of
?:pmid
?:pmid
  • 33649747
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33649747>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33649747>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all